Get a glimpse into our company and investor data—powered by the PitchBook Platform
Series A1LATEST DEAL TYPE
$20MLATEST DEAL AMOUNT
Operator of a bio-pharmaceutical company designed to offer vaccines. The company's SAPONEX products are critical components that are added to many vaccines, enabling people to improve their immunity system.